A phase 2 study of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma: ELEVATE HNSCC.A. Dimitrios Colevas, Douglas Adkins, Venessa Chin et al.|Journal of Clinical Oncology|2023Cited by 0